Sort
30,917 grants matching “tumor microenvironment”
Biology and Function of Exosomes in Cancer
$546,882Raghu Kalluri · University Of Tx Md Anderson Can Ctr · R35 · FY2022 · CA
Targeting Ferritin in Glioblastoma
$546,861Jeremy N Rich · Cleveland Clinic Lerner Com-Cwru · R01 · FY2013 · CA
Identification and characterization of cancer cell states by novel computational and experimental technologies - Resubmission - 1
$546,816Itai Yanai · New York University School Of Medicine · U01 · FY2024 · CA
Project 1- Elucidating oncogenic KRAS in PDAC cell signaling, resistance and immunity
$546,753Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2023 · CA
Project 1- Elucidating oncogenic KRAS in PDAC cell signaling, resistance and immunity
$546,751Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2021 · CA
Comparative analysis between patient-derived models of pancreatic ductal adenocarcinomas and matched tumor specimens
$546,688Rosalie C Sears · Oregon Health & Science University · U01 · FY2023 · CA
Copper-mediated metabolic reprogramming and ECM alterations in TNBC metastasis
$546,681Vivek Mittal · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA
Targeting iRhom to Improve Colon Cancer Immunochemotherapy
$546,625Song Li · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
An urinary drug disposing approach for treatment of bladder Cancer
$546,617Benedict Shek Hang Law · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA
Developing translationally-relevant genetically engineered mouse models of lung adenocarcinoma for investigations in cancer immunology
$546,612Nikhil Joshi · Yale University · R01 · FY2023 · CA
Activating Native Tumor Immunity with IL-33 Armored CARs
$546,511Yina Hsing Huang · Dartmouth College · R01 · FY2024 · CA
Toward Clinical Trial: AXL-STAT3 Targeting of Lung Tumor Microenvironments
$546,433Josephine A Taverna · University Of Texas Hlth Science Center · R01 · FY2024 · CA
An integrated approach to melanoma metastasis and therapy resistance: effects of age-related changes in the ECM and the biomechanics of the skin
$546,285Ashani T Weeraratna · Johns Hopkins University · R01 · FY2021 · CA
Project 1: Multi-scale modeling of adaptive drug resistance in BRAF-mutant melanoma
$546,237Peter Karl Sorger · Harvard Medical School · U54 · FY2021 · CA
Interrogating Type I Interferon signaling in breast cancer brain metastasis
$546,142Qing Chen · Research Inst Of Fox Chase Can Ctr · R01 · FY2025 · CA
Systemic RNA Delivery to Tumors
$546,127Jinjun Shi · Brigham And Women'S Hospital · R01 · FY2023 · CA
Systemic RNA Delivery to Tumors
$546,127Jinjun Shi · Brigham And Women'S Hospital · R01 · FY2025 · CA
Modulation of Therapeutic Response
$546,120James Mitchell · Division Of Clinical Sciences - Nci · ZIA · FY2009 · CA
Engineered antibody fragments for PET imaging of immunotherapeutic targets in gliomas
$546,013Gary Kohanbash · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · CA
Transcriptional and metabolic heterogeneity in T cell differentiation
$546,000Hongbo Chi · St. Jude Children'S Research Hospital · R01 · FY2024 · AI
Transcriptional and metabolic heterogeneity in T cell differentiation
$546,000Hongbo Chi · St. Jude Children'S Research Hospital · R01 · FY2025 · AI
PD-1 blockade with cryoablation and dendritic vaccine to treat lymphoma
$545,997Yi Lin · Mayo Clinic Rochester · R01 · FY2017 · CA
Glioma intelligence from behind enemy lines
$545,993Terry Burns · Mayo Clinic Rochester · R37 · FY2023 · CA
Towards Translation of MU-CN29: New Therapeutic Nanoparticle for Drug-Resistant NSCLC
$545,975Raghuraman Kannan · University Of Missouri-Columbia · R01 · FY2024 · CA
Modeling Perineural Invasion Using a Bioorthogonally Integrated Hydrogel Platform
$545,960Xinqiao Jia · University Of Delaware · · FY2018 · MPS